J. Goldman & Co LP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 63 filers reported holding SOLENO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 4.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$231,000
-61.9%
119,873
-50.5%
0.01%
-70.7%
Q3 2020$607,000
-37.6%
241,975
-44.8%
0.04%
-32.8%
Q2 2020$973,000
+189.6%
438,374
+210.6%
0.06%
+52.5%
Q1 2020$336,000
-45.1%
141,140
-32.2%
0.04%
-9.1%
Q4 2019$612,000208,3190.04%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 2,438,060$5,266,0001.15%
Vivo Capital, LLC 4,359,683$9,417,0000.95%
Trellus Management Company, LLC 152,829$330,0000.48%
SABBY MANAGEMENT, LLC 755,312$1,631,0000.21%
683 Capital Management, LLC 844,112$1,823,0000.12%
SHIKIAR ASSET MANAGEMENT INC 30,300$65,0000.02%
SECTORAL ASSET MANAGEMENT INC 21,587$47,0000.01%
Kepos Capital LP 37,591$81,0000.00%
DEUTSCHE BANK AG\ 86$00.00%
PANAGORA ASSET MANAGEMENT INC 11,851$26,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders